Literature DB >> 24639220

Hematopoietic long-term culture (hLTC) for human cytomegalovirus latency and reactivation.

Mahadevaiah Umashankar1, Felicia Goodrum.   

Abstract

Of the many research challenges posed by human cytomegalovirus latency, perhaps the most notable is the requirement for primary hematopoietic cell culture. Culturing hematopoietic subpopulations while maintaining physiological relevance must be given utmost consideration. We describe a long-standing primary CD34(+) hematopoietic progenitor cell (HPCs) system as an experimental model to study human cytomegalovirus (HCMV) latency and reactivation. Key aspects of our model include infection of primary human CD34(+) HPCs prior to ex vivo expansion, maintenance of undifferentiated cells in a long-term culture with a stromal cell support, and an assay to quantitate infectious centers produced prior to and following a reactivation stimulus. Our method offers a unique way to quantitatively assess HCMV latency and reactivation to study the contribution of viral and host genes in latency and reactivation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24639220     DOI: 10.1007/978-1-62703-788-4_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  25 in total

1.  Human Cytomegalovirus US28 Is Important for Latent Infection of Hematopoietic Progenitor Cells.

Authors:  Monica S Humby; Christine M O'Connor
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

2.  Alternative promoters drive human cytomegalovirus reactivation from latency.

Authors:  Donna Collins-McMillen; Mike Rak; Jason C Buehler; Suzu Igarashi-Hayes; Jeremy P Kamil; Nathaniel J Moorman; Felicia Goodrum
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-13       Impact factor: 11.205

3.  Inhibition of the FACT Complex Reduces Transcription from the Human Cytomegalovirus Major Immediate Early Promoter in Models of Lytic and Latent Replication.

Authors:  Christine M O'Connor; Masatoshi Nukui; Katerina V Gurova; Eain A Murphy
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

4.  Complex expression of the UL136 gene of human cytomegalovirus results in multiple protein isoforms with unique roles in replication.

Authors:  Katie Caviness; Louis Cicchini; Michael Rak; Mahadevaiah Umashankar; Felicia Goodrum
Journal:  J Virol       Date:  2014-10-08       Impact factor: 5.103

5.  Human cytomegalovirus G protein-coupled receptor US28 promotes latency by attenuating c-fos.

Authors:  Benjamin A Krishna; Monica S Humby; William E Miller; Christine M O'Connor
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-15       Impact factor: 11.205

6.  Human Cytomegalovirus Latency: Approaching the Gordian Knot.

Authors:  Felicia Goodrum
Journal:  Annu Rev Virol       Date:  2016-08-04       Impact factor: 10.431

7.  FOXO transcription factors activate alternative major immediate early promoters to induce human cytomegalovirus reactivation.

Authors:  Andrew E Hale; Donna Collins-McMillen; Erik M Lenarcic; Suzu Igarashi; Jeremy P Kamil; Felicia Goodrum; Nathaniel J Moorman
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-21       Impact factor: 11.205

8.  Selective 4-Thiouracil Labeling of RNA Transcripts within Latently Infected Cells after Infection with Human Cytomegalovirus Expressing Functional Uracil Phosphoribosyltransferase.

Authors:  Kathryn L Roche; Masatoshi Nukui; Benjamin A Krishna; Christine M O'Connor; Eain A Murphy
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

9.  Human Cytomegalovirus UL135 Interacts with Host Adaptor Proteins To Regulate Epidermal Growth Factor Receptor and Reactivation from Latency.

Authors:  Michael A Rak; Jason Buehler; Sebastian Zeltzer; Justin Reitsma; Belen Molina; Scott Terhune; Felicia Goodrum
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

10.  Long and Short Isoforms of the Human Cytomegalovirus UL138 Protein Silence IE Transcription and Promote Latency.

Authors:  Song Hee Lee; Katie Caviness; Emily R Albright; Jeong-Hee Lee; Christopher B Gelbmann; Mike Rak; Felicia Goodrum; Robert F Kalejta
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.